Valeria Szijárto

Title: Valeria Szijárto: Innovator in Antibody and Vaccine Development

Introduction

Valeria Szijárto is a prominent inventor based in Vienna, Austria. She has made significant contributions to the fields of immunology and vaccine development. With a total of two patents to her name, her work focuses on innovative solutions to combat infectious diseases.

Latest Patents

Valeria's latest patents include the development of O3 specific antibodies and a live attenuated Shigella vaccine. The O3 specific antibodies patent describes a cross-neutralizing monoclonal antibody that specifically recognizes a cross-reactive epitope of the lipopolysaccharide (LPS) antigen structure. This antibody is characterized by specific CDR sequences or VH and VL sequences. The live attenuated Shigella vaccine patent outlines a vaccine based on a rough strain lacking LPS O-antigen, designed for immunoprophylaxis to prevent infectious diseases, particularly enteral diseases. This vaccine utilizes a strain with specific gene deletions and a recombinant plasmid vector.

Career Highlights

Throughout her career, Valeria has worked with notable organizations such as Arsanis Biosciences GmbH and the Max Planck Society for the Advancement of Science. Her work in these institutions has allowed her to advance her research and contribute to significant scientific advancements.

Collaborations

Valeria has collaborated with esteemed colleagues, including Gábor Nagy and Eszter Nagy. These partnerships have enriched her research and fostered innovation in her field.

Conclusion

Valeria Szijárto is a remarkable inventor whose work in antibody and vaccine development is paving the way for new treatments against infectious diseases. Her contributions are vital to the ongoing efforts in immunology and public health.